Skip to main content
. 2021 Sep 15;21:1029. doi: 10.1186/s12885-021-08732-5

Fig. 5.

Fig. 5

In vivo antitumor activities of Nb36-treated DC-CIK cells in the established subcutaneous human tumor xenografts. A The tumor growth curves. Nb36-treated DC-CIK cells significantly reduced tumorvolume. n = 6, *** P < 0.001. B The survival of tumor-bearing mice. Nb36-treated DC-CIK cells prolonged the survival of tumor-bearing mice. n = 6, *** P < 0.001. C Quantitative analysis of KI-67 expression. Data are representative images (magnification × 400) or expressed as the mean ± SD from 5 randomly selected fields ofthin tumor sections. n = 6, ***P < 0.001